Your Eyes Are Dry Despite Using Drops. Here's Why.

Your VDR gene encodes a receptor that regulates how your immune system responds to vitamin D. When vitamin D binds to VDR, it activates anti-inflammatory signals that suppress overactive immune responses in your tissues, including your eyes and tear glands.

Certain VDR variants, carried by roughly 30-50% of the population depending on ancestry, reduce the receptor’s responsiveness to vitamin D signaling. This means your immune cells stay in a heightened inflammatory state even when vitamin D levels are adequate. Your body isn’t converting the vitamin D signal into immune tolerance the way it should.

In your eyes, this shows up as a chronic low-level inflammatory haze. Your tear glands mount a persistent immune attack on their own tissue. Your ocular surface stays irritated. Artificial tears can’t override this genetic predisposition toward inflammation.

MTHFR is the enzyme that converts dietary folate into its active form, methylfolate, which your cells use to generate nitric oxide. Nitric oxide is essential for vascular function, including the blood flow that nourishes your tear glands and ocular surface.

The MTHFR C677T variant, present in approximately 40% of people of European ancestry, reduces this enzyme’s activity by 40-70%. With a broken MTHFR step, your body cannot efficiently produce nitric oxide, and blood flow to your tear glands becomes impaired. Combined with higher homocysteine levels that damage small blood vessels, your tear glands become starved of oxygen and nutrients.

You experience progressive drying throughout the day. Your eyes feel worse by evening because the tissue has been under-perfused for hours. Even well-hydrated people with this variant can have chronically dry eyes because the vascular problem is encoded in their DNA, not fixable by drinking more water.

TNF-alpha is one of your body’s most powerful inflammatory signaling molecules. It tells immune cells to attack pathogens and infected tissue. But in people with TNF variants, the body produces too much TNF-alpha even in the absence of infection.

The TNF -308G>A variant, carried by roughly 30% of people of European ancestry, increases baseline TNF-alpha production. Your immune system is essentially running on a higher inflammatory baseline, and your tear glands become a target. Immune cells attack the tissue that produces tears, destroying gland function over time. Your eyes dry because the tissue that makes tears is under chronic immune assault.

This shows up as eyes that feel progressively worse despite no obvious infection or allergy. Your tears don’t taste salty or feel thick. They just feel absent. The problem is that your body is treating your tear glands as a threat that needs to be eliminated.

IL-6 is an inflammatory amplifier. Once the immune response starts, IL-6 signals tell other immune cells to join in. In people with IL6 variants, this amplifier is turned up too loud.

The IL6 -174G>C variant, present in approximately 40% of the population, increases baseline IL-6 production. Your inflammatory responses are amplified, and what should be a small, quick immune reaction becomes a sustained inflammatory storm. In your eyes, this means that even minor irritants trigger disproportionate inflammation. A dry day, a bit of dust, or a contact lens trigger hours of excess inflammation because your IL-6 system keeps the fire burning.

You might notice your dry eye is worse in winter, or worse on windy days, or worse after using screens. These aren’t quirks. Your IL-6 genetics means you cannot tolerate the environmental stresses that other people’s eyes handle without complaint.

Your eyes are metabolically expensive. Your photoreceptors and tear glands run on constant mitochondrial metabolism to generate energy. Mitochondria produce oxidative byproducts as a side effect. SOD2 is your mitochondrial cleanup enzyme. It neutralizes superoxide, the most damaging free radical produced inside your cells.

The SOD2 Val16Ala variant, present in roughly 40% of the population as the homozygous form, reduces SOD2 enzyme activity. Oxidative stress accumulates inside your ocular cells, triggering inflammatory pathways and accelerating cellular aging. Your tear-producing cells are bathed in oxidative damage, and they cannot function properly. Your ocular surface is similarly compromised.

You might notice your dry eye worsens with sun exposure, digital screen use, or air pollution. These are all conditions that increase oxidative stress. Your SOD2 genetics means your eyes cannot tolerate oxidative load that other people’s eyes handle easily.

COMT metabolizes dopamine and norepinephrine, two neurotransmitters that also function as anti-inflammatory signaling molecules in immune tissue. In people with the slow COMT variant, these molecules accumulate and sustain longer immune suppression. In people with the fast COMT variant, they’re cleared too quickly, leaving insufficient anti-inflammatory signaling.

The COMT Val158Met variant, present in roughly 25% of people as the homozygous slow form and 50% as heterozygous, creates either too much or too little anti-inflammatory signaling depending on which copy you inherited. Slow COMT can lead to excessive anti-inflammatory tone and immune dysregulation, while fast COMT leaves your immune system without sufficient dopaminergic anti-inflammatory brake. Both scenarios can increase ocular inflammation, though through different mechanisms.

Slow COMT carriers might notice their dry eye is worse when stressed or when they consume caffeine, stimulants, or high-catecholamine foods. Fast COMT carriers might notice their eyes are chronically inflamed regardless of these triggers. The underlying problem is that your dopaminergic immune regulation is not calibrated correctly.